Avastin bevacizumab: Completed Phase III trial enrollment

Genentech Inc. (DNA), South San Francisco, Calif. Product: Avastin bevacizumab Business: Cancer Therapeutic category: Antibodies Target: Vascular endothelial growth factor (VEGF) Description: Humani...